Moderna Inc. on Thursday forecast declining COVID-19 vaccine sales and rising costs for 2023, raising concerns the U.S. biotech company could post a loss this year, and its shares fell 7 percent. Moderna forecast $6 billion in costs for the year, $1 billion more than the revenue it expects to take in from sales of…
Moderna Forecasts COVID-19 Sales Decline as Costs Rise, Shares Fall
Protection From New COVID-19 Vaccines Drops Sharply Within Months: CDC
February 24, 2023
admin
AMERICACCP VirusCenters for Disease Control and PreventionEditor's PicksModernaPfizerUSUS NewsVaccines & Safety
0 Comment
The new COVID-19 vaccines provide a boost to protection against hospitalization but that shielding wanes within months, according to unpublished data presented on Feb. 24. A bivalent Pfizer or Moderna booster increased protection against hospitalization initially by 52 percent, but that protection dropped to 36 percent beyond 59 days, U.S. Centers for Disease Control and…
US Government Received $400 Million in COVID-19 Vaccine Royalty Payments: Moderna
February 23, 2023
admin
Business & MarketsCCP VirusCompaniesCOVID-19ModernaNational Institutes of HealthUSUS NewsVaccineVaccines & Safety
0 Comment
Moderna said on Feb. 23 that it recently reached a patent agreement with the U.S. government over disputed technology that is featured in its COVID-19 vaccine. In December 2022, Moderna entered “a nonexclusive patent license agreement” with the National Institute of Allergy and Infectious Diseases (NIAID), said CFO Jamey Mock during an earnings call on Thursday….
Moderna Reverses Course, Says People Won’t Have to Pay for COVID-19 Vaccine
Moderna has reversed course and promised that people will not have to pay for the company’s COVID-19 vaccine once the U.S. government stops buying shots. “Moderna remains committed to ensuring that people in the United States will have access to our COVID-19 vaccines regardless of ability to pay,” the company said in a statement. Moderna’s…
Moderna mRNA Flu Vaccine Trial Reports Mixed Results, Higher Adverse Reaction Rate
A large-scale human trial of Moderna’s mRNA seasonal flu vaccine yielded mixed interim results in terms of effectiveness and safety, the company said Thursday. The experimental vaccine, called mRNA-1010, is developed using the same technology as Moderna’s COVID-19 vaccines. It works by instructing the body’s cells to assemble hemagglutinin, a protein on the surface of…
US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit
The U.S. government is asserting that it, not Moderna, should face a lawsuit that alleges the company committed patent infringement with its COVID-19 vaccine. The government said the court should allow it to “relieve Moderna of any liability for patent infringement resulting in performance of the ’-0100 contract and to transfer to the United States…
Experts Want Labels for Pfizer, Moderna COVID-19 Vaccines Updated to Acknowledge Limitations
A coalition of experts is calling for U.S. officials to update the labels for the Pfizer and Moderna COVID-19 vaccines to acknowledge limitations to clinical trials, including stating clearly that the phase III trials that led to clearance did not provide evidence of efficacy against death. “Incomplete, inaccurate, or misleading labeling of any medical product…
Government-Purchased COVID-19 Treatments Set to Run Out—Here’s What to Expect
COVID-19 vaccines and treatments that have been free of charge to consumers, due to U.S. government funding, will eventually transition to be provided via the regular health care system. This means that certain COVID-19 tests, vaccines, and treatments, will cost more for some. Here’s what it means for you: End of Emergency Ashish Jha, the…
Elevated Rate of Facial Paralysis Identified After Pfizer COVID-19 Booster in Elderly: FDA
January 25, 2023
admin
adverse eventsAMERICACCP VirusEditor's PicksFood and Drug AdministrationModernaPfizerUSUS NewsVaccines & Safety
0 Comment
An elevated rate of Bell’s palsy was identified among elderly people after vaccination with a Pfizer booster shot, U.S. regulators said in a new study. The “small but statistically significant elevation” in Bell’s palsy was detected after vaccination with Pfizer’s old booster, which is no longer available in the United States, researchers with the U.S….
Moderna CEO Says He Wants to Have mRNA Vaccine Factory on Every Continent
Moderna chief executive Stephane Bancel said he wants to take his company’s mRNA vaccine manufacturing to every continent in the world, Reuters reported. “We’re talking to a couple more countries, because I would really like on every continent to have mRNA capacity,” Bancel said during a panel at the annual meeting of the World Economic…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`